- An unusual cause of distal duodenal bleeding
-
Chou JW, Cheng KS, Chuang SC
- KMID: 2425295
- Intest Res.
- 2016 Apr;14(2):197-198.
- doi: 10.5217/ir.2016.14.2.197
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A large symptomatic jejunal subepithelial tumor treated with endoloop-assisted polypectomy using spiral enteroscopy
-
Chou JW, Cheng KS, Lin CP
- KMID: 2174518
- Intest Res.
- 2016 Jan;14(1):104-105.
- doi: 10.5217/ir.2016.14.1.104
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary embolism in an immunocompetent patient with acute cytomegalovirus colitis
-
Chou JW, Cheng KS
- KMID: 2425293
- Intest Res.
- 2016 Apr;14(2):187-190.
- doi: 10.5217/ir.2016.14.2.187
Acute cytomegalovirus (CMV) infection occurs commonly in immunocompromised and immunocompetent patients, but is usually asymptomatic in the latter. Vascular events associated with acute CMV infection have been described, but are... -
- CITED
-
- Close
- SHARE
-
- Close
- Capsule retention caused by duodenal metastases from primary appendiceal adenocarcinoma
-
Chou JW, Cheng KS
- KMID: 2368496
- Intest Res.
- 2017 Jan;15(1):130-132.
- doi: 10.5217/ir.2017.15.1.130
Metastatic small bowel cancers are extremely rare in clinical practice. Primary appendiceal adenocarcinoma with gastrointestinal metastasis is seldom reported in the literature. Here, we describe the case of an 80-year-old... -
- CITED
-
- Close
- SHARE
-
- Close
- Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn's Disease
-
Yen HH, Chang CW, Chou JW, Wei SC
- KMID: 2394740
- Clin Endosc.
- 2017 Sep;50(5):417-423.
- doi: 10.5946/ce.2017.142
Inflammatory bowel diseases are idiopathic inflammatory diseases of two main types, Crohn's disease and ulcerative colitis. Crohn's disease can affect the entire gastrointestinal tract, and the distal ileum is involved... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
-
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM
- KMID: 2382372
- Intest Res.
- 2017 Jul;15(3):266-284.
- doi: 10.5217/ir.2017.15.3.266
Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
-
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM
- KMID: 2382373
- Intest Res.
- 2017 Jul;15(3):285-310.
- doi: 10.5217/ir.2017.15.3.285
Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
-
Lin WC, Chou JW, Yen HH, Hsu WH, Lin HH, Lin JK, Chuang CH, Huang TY, Wang HY, Wei SC, Wong JM
- KMID: 2396398
- Intest Res.
- 2017 Oct;15(4):487-494.
- doi: 10.5217/ir.2017.15.4.487
BACKGROUND/AIMS: In Taiwan, due to budget limitations, the National Health Insurance only allows for a limited period of biologics use in treating moderate to severe Crohn's disease (CD). We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study
-
Chang CW, Wei SC, Chou JW, Hsu TC, Chuang CH, Lin CP, Hsu WH, Yen HH, Lin JK, Fang YJ, Wang HY, Lin HH, Wu DC, Ni YH, Wang CY, Wong JM
- KMID: 2174405
- Intest Res.
- 2014 Oct;12(4):287-292.
- doi: 10.5217/ir.2014.12.4.287
BACKGROUND/AIMS: Only moderate to severe Crohn's Disease (CD) patients without a satisfactory conventional therapy effect are eligible to get reimbursement from the National Health Insurance of Taiwan for using adalimumab.... -
- CITED
-
- Close
- SHARE
-
- Close
